Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
Open Access
- 30 April 2007
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 8 (1) , 24
- https://doi.org/10.1186/1471-2350-8-24
Abstract
Background: Methylmalonic acidemia (MMA), a common organic aciduria, is caused by deficiency of the mitochondrial localized, 5'deoxyadenosylcobalamin dependent enzyme, methylmalonyl-CoA mutase (MUT). Liver transplantation in the absence of gross hepatic dysfunction provides supportive therapy and metabolic stability in severely affected patients, which invites the concept of using cell and gene delivery as future treatments for this condition.Methods: To assess the effectiveness of gene delivery to restore the defective metabolism in this disorder, adenoviral correction experiments were performed using murineMutembryonic fibroblasts and primary human methylmalonyl-CoA mutase deficient hepatocytes derived from a patient who harbored two early truncating mutations, E224X and R228X, in theMUTgene. Enzymatic and expression studies were used to assess the extent of functional correction.Results: Primary hepatocytes, isolated from the native liver after removal subsequent to a combined liver-kidney transplantation procedure, orMutmurine fibroblasts were infected with a second generation recombinant adenoviral vector that expressed the murine methylmalonyl-CoA mutase as well as eGFP from distinct promoters. After transduction, [1-14C] propionate macromolecular incorporation studies and Western analysis demonstrated complete correction of the enzymatic defect in both cell types. Viral reconstitution of enzymatic expression in the human methylmalonyl-CoA mutase deficient hepatocytes exceeded that seen in fibroblasts or control hepatocytes.Conclusion: These experiments provide proof of principle for viral correction in methylmalonic acidemia and suggest that hepatocyte-directed gene delivery will be an effective therapeutic treatment strategy in both murine models and in human patients. Primary hepatocytes from a liver that was unsuitable for transplantation provided an important resource for these studies.Keywords
This publication has 41 references indexed in Scilit:
- Propionyl-CoA and adenosylcobalamin metabolism in Caenorhabditis elegans: Evidence for a role of methylmalonyl-CoA epimerase in intermediary metabolismMolecular Genetics and Metabolism, 2006
- Principles of therapeutic liver repopulationJournal of Inherited Metabolic Disease, 2006
- Methylmalonic and propionic acidaemias: Management and outcomeJournal of Inherited Metabolic Disease, 2005
- Management of methylmalonic acidaemia by combined liver–kidney transplantationJournal of Inherited Metabolic Disease, 2004
- Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemiaThe Journal of Pediatrics, 1994
- Pancreatitis in patients with organic acidemiasThe Journal of Pediatrics, 1994
- Correction of methylmalonyl-CoA mutase deficiency inMut o fibroblasts and constitution of gene expression in primary human hepatocytes by retroviral-mediated gene transferSomatic Cell and Molecular Genetics, 1992
- Propionate metabolism in cultured human cells after overexpression of recombinant methylmalonyl CoA mutase: Implications for somatic gene therapySomatic Cell and Molecular Genetics, 1992
- Acute extrapyramidal syndrome in methylmalonic acidemia: “Metabolic stroke” involving the globus pallidusThe Journal of Pediatrics, 1988
- The Natural History of the Inherited Methylmalonic AcidemiasNew England Journal of Medicine, 1983